Strs Ohio Veracyte, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Veracyte, Inc. stock. As of the latest transaction made, Strs Ohio holds 28,600 shares of VCYT stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,600

Previous 34,000 15.88%

Holding current value

$1.06 Million

Previous $736,000 32.2%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$21.0 - $35.25 $113,400 - $190,350	-5,400 Reduced 15.88%	28,600 $973,000
Q2 2024 Aug 05, 2024	BUY	$18.86 - $23.55 $9,430 - $11,775	500 Added 1.49%	34,000 $736,000
Q1 2024 May 13, 2024	BUY	$21.0 - $29.1 $4,200 - $5,820	200 Added 0.6%	33,500 $742,000
Q4 2023 Jan 30, 2024	SELL	$19.72 - $28.68 $27,608 - $40,152	-1,400 Reduced 4.03%	33,300 $916,000
Q3 2023 Oct 26, 2023	BUY	$22.33 - $29.92 $17,864 - $23,936	800 Added 2.36%	34,700 $774,000
Q2 2023 Jul 31, 2023	SELL	$20.96 - $26.99 $33,536 - $43,184	-1,600 Reduced 4.51%	33,900 $863,000
Q1 2023 Aug 02, 2023	BUY	$20.58 - $27.89 $32,928 - $44,624	1,600 Added 4.72%	35,500 $791,000
Q1 2023 Apr 27, 2023	BUY	$20.58 - $27.89 $76,146 - $103,193	3,700 Added 11.64%	35,500 $791,000
Q4 2022 Jan 26, 2023	SELL	$15.31 - $29.94 $211,278 - $413,172	-13,800 Reduced 30.26%	31,800 $754,000
Q3 2022 Oct 27, 2022	BUY	$16.58 - $27.9 $14,921 - $25,110	900 Added 2.01%	45,600 $756,000
Q2 2022 Jul 25, 2022	BUY	$15.45 - $29.52 $194,670 - $371,952	12,600 Added 39.25%	44,700 $889,000
Q1 2022 Apr 21, 2022	BUY	$21.94 - $42.51 $50,462 - $97,773	2,300 Added 7.72%	32,100 $884,000
Q3 2021 Oct 22, 2021	SELL	$35.62 - $52.97 $89,050 - $132,425	-2,500 Reduced 7.74%	29,800 $1.38 Million
Q2 2021 Jul 26, 2021	BUY	$32.94 - $56.62 $98,820 - $169,860	3,000 Added 10.24%	32,300 $1.29 Million
Q1 2021 Apr 23, 2021	BUY	$44.47 - $81.38 $195,668 - $358,072	4,400 Added 17.67%	29,300 $1.57 Million
Q4 2020 Jan 25, 2021	SELL	$32.49 - $61.88 $139,707 - $266,084	-4,300 Reduced 14.73%	24,900 $1.22 Million
Q3 2020 Dec 14, 2020	BUY	$26.73 - $35.67 $665,577 - $888,183	24,900 Added 579.07%	29,200 $948,000
Q2 2020 Jul 23, 2020	BUY	$19.49 - $28.11 $7,795 - $11,244	400 Added 10.26%	4,300 $111,000
Q1 2020 Apr 23, 2020	SELL	$16.13 - $30.17 $432,284 - $808,556	-26,800 Reduced 87.3%	3,900 $94,000
Q4 2019 Jan 24, 2020	SELL	$20.78 - $29.99 $43,638 - $62,979	-2,100 Reduced 6.4%	30,700 $857,000
Q3 2019 Oct 21, 2019	BUY	$23.87 - $30.93 $21,483 - $27,837	900 Added 2.82%	32,800 $787,000
Q2 2019 Jul 25, 2019	SELL	$22.1 - $28.56 $44,200 - $57,120	-2,000 Reduced 5.9%	31,900 $909,000
Q1 2019 Apr 19, 2019	SELL	$12.0 - $25.76 $189,600 - $407,008	-15,800 Reduced 31.79%	33,900 $848,000
Q4 2018 Jan 23, 2019	SELL	$9.15 - $14.85 $179,340 - $291,060	-19,600 Reduced 28.28%	49,700 $625,000
Q3 2018 Oct 19, 2018	BUY	$9.55 - $12.64 $271,220 - $358,976	28,400 Added 69.44%	69,300 $661,000
Q2 2018 Aug 06, 2018	BUY	$5.39 - $9.66 $19,943 - $35,742	3,700 Added 9.95%	40,900 $382,000
Q3 2017 Oct 23, 2017	BUY	$7.81 - $8.77 $290,532 - $326,244	37,200	37,200 $326,000

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.3M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.65B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account